NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

**media[736448]**NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn statusKristen Scholer delivers the pre-market update on September 4thStocks are fractionally higher Thurs…

Enveda raises another $150M, claims unicorn status – BizWest

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, recently closed a $150 million Series D funding round led by Premji Invest.

Enveda collects another $150M for I&I drug, sprawling pipeline of preclinical assets

A Colorado biotech has gone from a $50,000 "pre, pre-seed" check from its founding CEO to $517 million in funding and unicorn status in five years. Enveda hit the $1 billion valuation milestone — a relative ...